Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Blood Pressure Drug Recalled Due to Cancer Risk

Irbesartan tablets have been recalled due to the presence of an impurity believed to cause cancer.

Irbesartan / Image: Stada
Irbesartan / Image: Stada

A November 2nd USA Today article discussed the recall of a blood pressure medication that was recalled due to an impurity linked to cancer. Irbesartan tablets produced by ScieGen Pharmaceuticals are the subjects of the voluntary recall. They were sold in 75, 150, and 300 mg doses and labeled as Westminster Pharmaceuticals and Golden State Medical Supply, Inc.

The drug, which is prescribed to treat high blood pressure and kidney disease, was found to contain N-nitrosodiethylamine (NDEA). NDEA occurs naturally in certain foods, drinking water, air pollution, and industrial processes and is listed as a probable human carcinogen, according to The International Agency for Research on Cancer. ScieGen noted that the company has not been made aware of any adverse events related to the recall.

Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO